SCHEMBL2801533

SCHEMBL2801533

c1cnc2cc3nccnc3cc2c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.58
POLB P06746 2/20 0.58
RAB9A P51151 2/20 0.58
PDGFRB P09619 1/20 0.55
PDGFRA P16234 1/20 0.55
ALDH1A1 P00352 6/20 0.54
MAPT P10636 5/20 0.54
HTT P42858 3/20 0.54
KDM4E B2RXH2 3/20 0.54
MEN1 O00255 3/20 0.54
KMT2A Q03164 3/20 0.54
CASP1 P29466 2/20 0.54
TP53 P04637 2/20 0.54
HSP90AA1 P07900 2/20 0.54
TSHR P16473 2/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
ATM Q13315 2/20 0.54
CASP7 P55210 1/20 0.54
CYP1A2 P05177 1/20 0.54
CYP2C19 P33261 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30372045 1.00 NPC1 (0.58) NPC1POLBRAB9APDGFRBPDGFRA
SCHEMBL29350099 0.92 NPC1 (0.65) NPC1POLBRAB9APDGFRBPDGFRA
SCHEMBL150476 0.92 NPC1 (0.65) NPC1POLBRAB9APDGFRBPDGFRA
SCHEMBL6647315 0.90 NPC1 (0.62) NPC1POLBRAB9APDGFRBPDGFRA
SCHEMBL13156520 0.87 NPC1 (0.60) NPC1POLBRAB9APDGFRBPDGFRA
SCHEMBL18700662 0.87 NPC1 (0.60) NPC1POLBRAB9APDGFRBPDGFRA
SCHEMBL13156510 0.87 NPC1 (0.60) NPC1POLBRAB9APDGFRBPDGFRA
SCHEMBL12532559 0.87 NPC1 (0.60) NPC1POLBRAB9APDGFRBPDGFRA
SCHEMBL29726025 0.85 ALDH1A1 (0.61) NPC1POLBRAB9APDGFRBPDGFRA
SCHEMBL50867 0.85 ALDH1A1 (0.61) NPC1POLBRAB9APDGFRBPDGFRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2408750-B1 PROCESS FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMA (US) 2015-08-26 EP disclosed
US-7880164-B2 electroconductive polysilsesquioxanes; strong adhesion to an electrode material, such as ITO or IZO; durability SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2011-02-01 US disclosed
US-20100209537-A1 Metal complexes with anticancer activity BANGALORE RAMESH 2010-08-19 US disclosed
WO-2008081266-A1 COMPOUNDS FOR THE TREATMENT OR PREVENTION OF INFECTION BY FLAVIVIRIDAE CARTA ANTONIO (IT) 2008-07-10 WO disclosed
EP-1242382-B1 TRICYCLIC PROTEIN KINASE INHIBITORS WYETH CORP (US) 2007-02-07 EP disclosed
US-6251903-B1 Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones and the use thereof as glycine receptor antagonist COCENSYS, INC. 2001-06-26 US disclosed
US-6147075-A ANALGESICS; PSYCHOLOGICAL DISORDERS COCENSYS, INC. (US) 2000-11-14 US disclosed
EP-0732942-A4 ALKYL, AZIDO, ALKOXY, AND FLUORO-SUBSTITUTED AND FUSED QUINOXALINEDIONES AND THE USE THEREOF AS GLYCINE RECEPTOR ANTAGONISTS COCENSYS INC (US) 2000-03-22 EP disclosed
US-5977107-A Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones and the use thereof as glycine receptor antagonists COCENSYS, INC. (US) 1999-11-02 US disclosed
US-5631373-A NERVOUS SYSTEM DISORDERS STATE OF OREGON, ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION, ACTING FOR AND ON BEHALF OF THE OREGON HEALTH SCIENCES UNIVERSITY AND THE UNIVERSITY OF OREGON, EUGENE OREGON (US) 1997-05-20 US disclosed
EP-0732942-A1 ALKYL, AZIDO, ALKOXY, AND FLUORO-SUBSTITUTED AND FUSED QUINOXALINEDIONES AND THE USE THEREOF AS GLYCINE RECEPTOR ANTAGONISTS ACEA PHARMACEUTICALS, INC. (US) 1996-09-25 EP disclosed
WO-1995012417-A1 ALKYL, AZIDO, ALKOXY, AND FLUORO-SUBSTITUTED AND FUSED QUINOXALINEDIONES AND THE USE THEREOF AS GLYCINE RECEPTOR ANTAGONISTS ACEA PHARMACEUTICALS, INC. (US) 1995-05-11 WO disclosed